199 related articles for article (PubMed ID: 19358839)
1. Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.
Fisher CD; Lickteig AJ; Augustine LM; Oude Elferink RP; Besselsen DG; Erickson RP; Cherrington NJ
Eur J Pharmacol; 2009 Jun; 613(1-3):119-27. PubMed ID: 19358839
[TBL] [Abstract][Full Text] [Related]
2. Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression.
Clarke JD; Hardwick RN; Lake AD; Canet MJ; Cherrington NJ
J Pharmacol Exp Ther; 2014 Mar; 348(3):452-8. PubMed ID: 24403518
[TBL] [Abstract][Full Text] [Related]
3. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease.
Lickteig AJ; Fisher CD; Augustine LM; Aleksunes LM; Besselsen DG; Slitt AL; Manautou JE; Cherrington NJ
Drug Metab Dispos; 2007 Oct; 35(10):1970-8. PubMed ID: 17640958
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction between genetics and disease on pravastatin disposition.
Clarke JD; Hardwick RN; Lake AD; Lickteig AJ; Goedken MJ; Klaassen CD; Cherrington NJ
J Hepatol; 2014 Jul; 61(1):139-47. PubMed ID: 24613363
[TBL] [Abstract][Full Text] [Related]
5. Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.
Cheng X; Klaassen CD
Toxicol Sci; 2008 Nov; 106(1):37-45. PubMed ID: 18703564
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis.
Hardwick RN; Fisher CD; Street SM; Canet MJ; Cherrington NJ
Drug Metab Dispos; 2012 Mar; 40(3):450-60. PubMed ID: 22112382
[TBL] [Abstract][Full Text] [Related]
7. Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet.
Cho SJ; Kim SB; Cho HJ; Chong S; Chung SJ; Kang IM; Lee JI; Yoon IS; Kim DD
J Agric Food Chem; 2016 Jul; 64(27):5598-606. PubMed ID: 27321734
[TBL] [Abstract][Full Text] [Related]
8. Intestinal ischemia-reperfusion suppresses biliary excretion of hepatic organic anion transporting polypeptides substrate.
Maruyama H; Ogura J; Fujikawa A; Terada Y; Tsujimoto T; Koizumi T; Kuwayama K; Kobayashi M; Yamaguchi H; Iseki K
J Pharm Pharm Sci; 2013; 16(5):722-31. PubMed ID: 24393554
[TBL] [Abstract][Full Text] [Related]
9. Modeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models.
Canet MJ; Hardwick RN; Lake AD; Dzierlenga AL; Clarke JD; Cherrington NJ
Drug Metab Dispos; 2014 Apr; 42(4):586-95. PubMed ID: 24384915
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats.
Shitara Y; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
Drug Metab Dispos; 2009 Jun; 37(6):1172-8. PubMed ID: 19282398
[TBL] [Abstract][Full Text] [Related]
11. A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model.
Montonye ML; Tian DD; Arman T; Lynch KD; Hagenbuch B; Paine MF; Clarke JD
J Pharmacol Exp Ther; 2019 Nov; 371(2):385-393. PubMed ID: 31420525
[TBL] [Abstract][Full Text] [Related]
12. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
Gao Y; Song LX; Jiang MN; Ge GY; Jia YJ
Inflammation; 2008 Apr; 31(2):121-32. PubMed ID: 18302012
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury.
Fujiyama N; Shitara Y; Ito K; Masubuchi Y; Horie T
Biol Pharm Bull; 2007 Mar; 30(3):556-61. PubMed ID: 17329856
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity.
Clarke JD; Dzierlenga A; Arman T; Toth E; Li H; Lynch KD; Tian DD; Goedken M; Paine MF; Cherrington N
Toxicon; 2019 Apr; 162():1-8. PubMed ID: 30849452
[TBL] [Abstract][Full Text] [Related]
15. Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs.
Liang R; Ge W; Li B; Cui W; Ma X; Pan Y; Li G
Pharm Biol; 2022 Dec; 60(1):359-373. PubMed ID: 35171063
[TBL] [Abstract][Full Text] [Related]
16. Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.
Canet MJ; Hardwick RN; Lake AD; Dzierlenga AL; Clarke JD; Goedken MJ; Cherrington NJ
Drug Metab Dispos; 2015 Feb; 43(2):266-72. PubMed ID: 25488932
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps).
Cheng X; Maher J; Chen C; Klaassen CD
Drug Metab Dispos; 2005 Jul; 33(7):1062-73. PubMed ID: 15843488
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.
Le Vee M; Gripon P; Stieger B; Fardel O
Drug Metab Dispos; 2008 Feb; 36(2):217-22. PubMed ID: 17991769
[TBL] [Abstract][Full Text] [Related]
19. Characterization of organic anion-transporting polypeptide (Oatp) 1a1 and 1a4 null mice reveals altered transport function and urinary metabolomic profiles.
Gong L; Aranibar N; Han YH; Zhang Y; Lecureux L; Bhaskaran V; Khandelwal P; Klaassen CD; Lehman-McKeeman LD
Toxicol Sci; 2011 Aug; 122(2):587-97. PubMed ID: 21561886
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver.
Geier A; Dietrich CG; Voigt S; Ananthanarayanan M; Lammert F; Schmitz A; Trauner M; Wasmuth HE; Boraschi D; Balasubramaniyan N; Suchy FJ; Matern S; Gartung C
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G831-41. PubMed ID: 15860642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
